China Tracker - Details for Biostar Pharmaceuticals (BSPM)

 Biostar Pharmaceuticals
 Basic Facts and History
Data Source: Annual Report for the period ended 2010-12-31
Reporting Type: U.S. Company (10-K Filings) 
Incorporation: Maryland 
Corporate Headquarters: China (Shaanxi) 
Going Public: Direct Offering on 2007-11-01 
Uplisting to Senior Exchange: on 2010-04-23 at $14.04 (-87.18% since Uplisting)
Main Operating Subsidiary: Shaanxi Aoxing Pharmaceutical Co., founded 1997 
Investor Relations: Investor Relations Website 
Internal Controls: effective 
Internal Controls Audit: not performed 
Auditor Opinion:

The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. (Mazars CPA)

 
 Ownership
Main Shareholder: Ronghua Wang (Chairman, CEO) 
Ownership: 33.28% 
 
 Auditor Trail (since January 1, 2009)
2010-01-22Mazars CPAAppointment
2010-01-22Acquavella, Chiarelli, Shuster, Berkower & Co.Dismissal
2009-06-30Acquavella, Chiarelli, Shuster, Berkower & Co.Appointment
2009-06-30Morgenstern, Svoboda & BaerResignation
 
 Senior Management Trail (since January 1, 2009)
2011-04-07Zack Zibing PanCFOAppointment
2011-04-06Deyin ChenCFOResignation
2010-07-01Deyin ChenCFOAppointment
2010-06-30Elaine ZhaoCFOResignation
2007-07-01Elaine ZhaoCFOAppointment
 
 Fiscal Year
Fiscal Year ends: December 31 
First Quarter 10-Q: due by 2018-05-15 
Second Quarter 10-Q: due by 2018-08-15 
Third Quarter 10-Q: due by 2017-11-15 
Annual Report 10-K: due by 2018-03-31 
BSPM
Healthcare & Drugs
SCORE
7
READ: Score Cards Explained
SAFETY/RISK SCORE
EXTREME RISK
DETAILS: Safety/Risk Model for BSPM
Current Price:  $1.80
F10k Day (2009-08-14): -85.00%$12.00
2009 Close: -86.52%$13.35
2010 Close: -78.73%$8.46
2011 Close: -3.23%$1.86
High (2012-04-23): -14.70%$2.11
Low (2012-04-03): 221.42%$0.56
Exchange: NCM
Market Capitalization: 16.92 mill
Total Shares: 9.40 mill
Float: 2,220,000.00 mill
Avg Volume: 153.20 k
Short Interest: 47.90 k
Short Ratio: 0.08%0.3 d
Last Quarter: 2012-06-30
Revenue (MRQ): 8.16 mill
Net Income (MRQ): -1.58 mill
Op. Cash Flow (MRQ): -3.02 mill
all financial data provided without warranty